1. Short title This Act may be cited as the Mobile Options for Testing In Our Neighborhoods Act or the MOTION Act . 2. Mobile testing for SARS–CoV–2 and COVID–19 (a) In general Not later than 120 days after the date of the enactment of this Act, the Secretary of Health and Human Services (in this Act referred to as the Secretary ) shall award grants to establish, improve, and maintain mobile testing programs to conduct testing for SARS–CoV–2 and COVID–19. (b) Eligible entity In this section, the term eligible entity means— (1) a health center (as defined in section 330 of the Public Health Service Act ( 42 U.S.C. 3 254b)), including community health centers; (2) a federally qualified health center (as defined in section 1861 of the Social Security Act ( 42 U.S.C. 1395x )); (3) a rural health clinic (as defined in section 1861 of the Social Security Act ( 42 U.S.C. 1395x )); (4) a State, local, Tribal, or territorial health department; (5) medical centers and research labs at an institution of higher education (as defined in section 101 of the Higher Education Act of 1965 ( 20 U.S.C. 1001 )); (6) nonprofit organizations; and (7) any other entity as determined by the Secretary. (c) Use of funds An eligible entity receiving grant funds under subsection (a) shall use the funds to— (1) purchase equipment and supplies to conduct mobile testing for SARS–CoV–2 and COVID–19; (2) serve multiple communities (including zip codes or cities) in a period determined by the Secretary; (3) purchase, lease, and maintain mobile vehicles and equipment to conduct such testing; (4) hire and train laboratory personnel and other staff to conduct such testing; (5) provide or administer, as the case may be— (A) vaccines licensed under section 351 of the Public Health Service Act ( 42 U.S.C. 262 ) for SARS–CoV–2 or COVID–19; and (B) drugs and biological products— (i) approved under sections 505 and 564 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 and 360bbb–3) for SARS–CoV–2 or COVID–19